Details of CPPsite entry with Sequence GRKKRRQRRRPPQC |
Primary information | |
---|---|
PEPTIDE SEQUENCE | GRKKRRQRRRPPQC |
CPPsite ID | 2666, 1438, 1740, 1831, |
PEPTIDE NAME | TAT, Tat ARM, PN173 (SEQ ID NO: 36), HIV-1 Tat (48-60) |
CHIRALITY | L, L, L, L |
LINEAR/CYCLIC | Linear, Linear, Linear, Linear |
SOURCE | Synthetic, Protein derived, Synthetic, Protein derived |
CATEGORY | Cationic and amphipathic, Cationic, Unknown, Cationic |
SUB CELLULAR LOCALIZATION | NA, Cytoplasm and nucleus, Unknown, Only punctate distribution (vesicles) |
N-TERMINAL MODIFICATION | NA, Conjugation with rhodamine B, Free, Free |
C-TERMINAL MODIFICATION | Amidation, Amidation, Amidation, Conjugation with Alexa 488 at glycyl cysteine sequence |
CHEMICAL MODIFICATION | NA, NA, NA, NA |
UPTAKE EFFICIENCY | Accumulations were only slightly different from that of the control GC peptide in tumors, Unknown, Unknown, Unknown |
PROPOSED UPTAKE MECHANISM | NA, Non-endocytic pathway, Unknown, Endocytic pathway (Macropinocytosis) |
INVITRO/INVIVO | In vivo, In vitro, In vitro, In vitro |
CELL LINE | NA, HeLa, 9 L/LacZ cells, CHO-K1, HeLa and Jurkat |
In VIVO MODEL | Tumor-xenografted nude mice, NA, NA, NA |
CARGO | Fluorophore (Alexa660), Fluorophore (rhodamine), Nucleic acid (siRNA), Fluorophore (Alexa-488) |
PMID | 22285548, 12119035, 19707187 |
PATENT | Unknown, US 20040132970, US 20060035815, US 20040132970 |
Tertiary Structure (Technique) | 2666 (PEPstrMOD), 1438 (PEPstrMOD), 1740 (PEPstrMOD), 1831 (PEPstrMOD), |